Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eli Casdin
AddedMar 31, 2024
UpdatedMay 1, 2026
Eli Casdin

Eli Casdin

Founder, Casdin Capital

Eli Casdin's Career

Casdin Capital
Casdin Capital

New York City, NY, US

Founder
Cedilla Therapeutics
Cedilla Therapeutics

Cambridge, MA, US

Board Member· Board
Vineti
Vineti

San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eli Casdin's Career

Casdin Capital
Casdin Capital
Investment FirmInvestment Firm492012New York City, NY, US
Founder

Leadership at Casdin Capital

Alan HuangAlan HuangBoard Member

Similar to Casdin Capital

Foresite CapitalForesite CapitalSan Francisco, CA, USest. 2011Foresite CapitalSan Francisco, CA, US · est. 2011

Foresite Capital: A leading US venture capital & growth equity firm, headquartered in San Francisco.

Investment Firm68
Amicus Capital PartnersAmicus Capital PartnersChicago, IL, USAmicus Capital PartnersChicago, IL, US

Healthcare investment firm specializing in equity capital for mid-market biotech and medical sectors.

Investment Firm7
Capitan Investment PartnersCapitan Investment PartnersWashington, D.C., DC, USCapitan Investment PartnersWashington, D.C., DC, US

Investing in tech firms at all stages.

Investment Firm5
Candou VenturesCandou VenturesPalo Alto, CA, USest. 2015Candou VenturesPalo Alto, CA, US · est. 2015

Candou Ventures LLC: A US-based venture capital firm investing in biotech, education, healthcare, and AI sectors.

Investment Firm8
Cedilla Therapeutics
Cedilla Therapeutics
Series B$138.8M452018Cambridge, MA, US
Board Member· Board

Leadership at Cedilla Therapeutics

Matthew P JacobsonMatthew P JacobsonCo-Founder
Abbie CelnikerAbbie CelnikerBoard Member
Neil ExterNeil ExterBoard Member
William KaelinWilliam KaelinCo-Founder
Alan D'AndreaAlan D'AndreaCo-Founder
Steve GygiSteve GygiCo-Founder
Vineti
Vineti
Series C$115.3M3752016San Francisco, CA, US
Board Member· Board

Recent news

a16z-backed Rooms.xyz lets you build interactive, 3D rooms and simple games in your browserTechCrunch · 2023

Leadership at Vineti

Stephen TingStephen TingCo-Founder
Emily MeltonEmily MeltonBoard Member
Amy DurossAmy DurossCo-Founder
Heidi HagenHeidi HagenCo-Founder
Nina KjellsonNina KjellsonBoard Member
Ann KleinAnn KleinCEO

Similar to Vineti

Vita TherapeuticsVita TherapeuticsBaltimore, MD, USCell Therapiesest. 2018Vita TherapeuticsBaltimore, MD, US · est. 2018

Vita Therapeutics: Pioneering life-transformative treatments through cell engineering.

Series B · $63M33
ViTToria BiotherapeuticsViTToria BiotherapeuticsPhiladelphia, PA, USCell Therapiesest. 2021ViTToria BiotherapeuticsPhiladelphia, PA, US · est. 2021

Vittoria Biotherapeutics pioneers in gene-edited T-cell therapies, enhancing efficacy and safety in cell-based treatments.

Series B · $25M34
VintaBioVintaBioPhiladelphia, PA, USViral Vectorsest. 2020VintaBioPhiladelphia, PA, US · est. 2020

VintaBio: Expert CDMO provider for viral vectors, advancing cell and gene therapy manufacturing.

Series D · $64M15
Endpoint HealthEndpoint HealthPalo Alto, CA, USTests, Therapeuticsest. 2018Endpoint HealthPalo Alto, CA, US · est. 2018

Endpoint Health: Personalized therapies for immune-driven illnesses, improving patient outcomes.

Series D · $64.2M

Eli Casdin's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Eli Casdin

Neil PeplinskiNeil PeplinskiBoard Member · Cedar CapitalYong-Fei ChaoYong-Fei ChaoBoard Member · CSC Venture CapitalMichael Scott CohenMichael Scott CohenBoard Member · TomsEli LevyEli LevyCEO · Y.D. More InvestmentsAri PaulAri PaulCo-Founder · BlockTower CapitalKyle CerminaraKyle CerminaraBoard Member · FG Financial Group